Get the Stockscreener App
2.025
1.50%
0.03
Im Cannabis Corp stock is traded at $2.025, with a volume of 5,636.
It is up +1.50% in the last 24 hours and down -10.79% over the past month.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
See More
Previous Close:
$1.995
Open:
$2.02
24h Volume:
5,636
Relative Volume:
0.38
Market Cap:
$4.45M
Revenue:
$77.52M
Net Income/Loss:
$-52.14M
P/E Ratio:
-0.1154
EPS:
-17.552
Net Cash Flow:
$-8.37M
1W Performance:
-6.68%
1M Performance:
-10.79%
6M Performance:
-62.07%
1Y Performance:
-28.39%
1-Day Range:
$2.00
$2.05
1-Week Range:
$1.93
$2.19
52-Week Range:
$1.134
$8.10
Im Cannabis Corp Stock (IMCC) Company Profile
Im Cannabis Corp Stock (IMCC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-05-21 | Initiated | ROTH Capital | Buy |
| Jul-14-21 | Initiated | Desjardins | Buy |
Im Cannabis Corp Stock (IMCC) Latest News
IM Cannabis Corp: Revenue Surge and Expansion Plans - TipRanks
IMC applauds the April 1st implementation of the new Israeli can - GuruFocus.com
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis - GuruFocus.com
IM Cannabis Announces Appointment of Shmulik Arbel to Board of D - GuruFocus.com
IM Cannabis Reports Second Quarter Financial Results - GuruFocus.com
IM Cannabis Closes Convertible Debenture Offering to Support Acc - GuruFocus.com
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management - Barchart
How Cannabis Legalization in Germany Boosted IM Cannabis’ Revenue: Will Spain’s Medical Marijuana Framework Do the Same? | Home - 420 Intel
IM Cannabis announces $1.6 million private placement to repay loan - Marijuana Business Daily
IM Cannabis Corp (IMCC) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges - GuruFocus.com
IM Cannabis announces private placement offering - Investing.com
IM Cannabis announces private placement offering By Investing.com - Investing.com South Africa
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know - Benzinga
IM Cannabis plans $1.6M private placement, reshuffles options - Green Market Report
IM Cannabis Corp. Plans Private Placement and Restructures Incentives - TipRanks
IM Cannabis Corp. announced that it expects to receive $1.613 million in funding - Marketscreener.com
How Cannabis Legalization in Germany Boosted IM Cannabis’ Revenue: Will Spain’s Medical Marijuana Framework Do the Same? - TimesOfCannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same? - Benzinga
IMC Germany reports 50% Q3 revenue growth over Q2 By Investing.com - Investing.com South Africa
IMC Germany reports 50% Q3 revenue growth over Q2 - Investing.com
IM Cannabis says sales in Germany up 50% - Green Market Report
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 - Lelezard
IM Cannabis IMC Germany reported preliminary 50% increase in revenue - TipRanks
IM Cannabis Corp. Sees Soaring Q3 Growth in Germany - TipRanks
IM Cannabis Corp Refocuses Strategy Amidst Expansion - TipRanks
IM Cannabis Appoints Shmulik Arbel to Board of Directors - mg Magazine
Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch - Simply Wall St
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors - KelownaNow
IM Cannabis adds finance veteran Shmulik Arbel to board - Investing.com India
IM Cannabis adds finance veteran Shmulik Arbel to board By Investing.com - Investing.com Australia
IM Cannabis Strengthens Board with Finance Expert - TipRanks
IM Cannabis Corp. Appoints Shmulik Arbel to Board of Directors - Marketscreener.com
IM Cannabis Corp: Strategic Refocus Amidst Challenges - TipRanks
IMC welcomes new Israeli cannabis regulations which are about to - GuruFocus.com
IM Cannabis Corp. (IMCC) Reports Q2 Loss, Tops Revenue Estimates - MSN
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany - Longview News-Journal
IM Cannabis stok holds Buy rating amid German growth By Investing.com - Investing.com Canada
IM Cannabis stok holds Buy rating amid German growth - Investing.com
Earnings call: IM Cannabis sees growth in German market post-legalization - Investing.com Canada
IM Cannabis repots Q2 EPS (23c) vs. (26c) last year - TipRanks
IM Cannabis records another loss in Q2, despite boost from German market - Green Market Report
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY - Benzinga
IM Cannabis Corp. Sees Soaring Sales in Germany - TipRanks
IM Cannabis Corp expected to post a loss of C$1.17 a shareEarnings Preview - XM
Im Cannabis Corp Stock (IMCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):